Citi analyst Patrick Cunningham upgraded Eastman Chemical (EMN) to Buy from Neutral with a price target of $101, down from $105. The company is in a relatively better position amid the tariff uncerintaty with solid growth from innovation-driven platforms helping offset near-term pressure, the analyst tells investors in a research note. The firm believes Eastman has potential for more stable growth profile despite the backdrop of consumer and industrial uncertainty. The company’s path to modest earnings growth is achievable with $50M in cost reduction actions and better operating performance from methanolysis, contends Citi.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMN:
- Eastman Chemical upgraded to Buy from Neutral at Citi
- Mizuho upgrades Eastman Chemical to Outperform on rising earnings estimates
- Eastman Chemical upgraded to Outperform from Neutral at Mizuho
- Eastman Chemical management to meet with KeyBanc
- Eastman Chemical Announces Severance Agreement with Executive